drugset / Trial / NCT05743764
HU007 in Patients with Dry Eye Syndrome
RandomizedFactorialDouble-blindTreatment
Summary
A multicenter, Randomized, Double blind, Restasis®-controlled Non-inferiority, Moisview® Eye Drops Controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome
Timeline
- Start
- 2023-03-23
- Primary completion
- 2024-02-14
- Completion
- 2024-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.02 % | Other |
| Subject | Cyclosporine | Peptide | 0.05 % | Other |
| Subject | Trehalose | Small molecule | 3 % | Other |